Press Releases

The global CDSS market is expected to witness a CAGR of 6.5% during the forecast period 2025-2030. CDSS is used at point-of-care and is interoperable. The major factors driving the growth of the CDSS market are the initiatives taken by the government worldwide, rise in usage of information systems by hospitals and healthcare institutes. The global CDSS market is anticipated to have innovation due to massive investment in R&D projects. Market participants are signing licensing agreements with major hospitals and healthcare groups to expand their consumer base. Integrating interoperability and cloud computing platforms across different systems will further promote smooth operation and seamless data flow, thereby accelerating the adoption of CDSS.

The COVID-19 pandemic has increased the need to maintain social distancing between doctors and patients, driving demand for remote patient monitoring and telemedicine solutions, as well as the need for accurate and timely exchange of medical records from the patients. Several market participants have introduced COVID-19 related features into their existing EHRs, and these features are offered to users free of charge.

In March 2020, IBM Watson Health and EBSCO Information Services announced a strategic collaboration aimed toward enhancing clinical decision support (CDS) and operations for healthcare providers and health systems. The companies have designed a combined solution suite to bring together drug and disease content into a single source for evidence-based insights called DynaMed and Micromedex with Watson, to help inform clinical decisions.

Browse 93 market data Tables and 56 Figures spread through 220 Pages and in-depth TOC on " CDSS Market by Product (Integrated CDSS and Standalone CDSS), by Mode  of Delivery (On Premise Delivery Model, Web-Based Delivery Model, and Cloud-Based Delivery Model), by Model (Knowledge-Based CDSS and Non-Knowledge Based CDSS), by Component (Hardware, Software, and Services), by Application(Drug-Drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, and Others), by Level of Interactivity (Active CDSS and Passive CDSS), by Settings (Inpatient Settings and Ambulatory Care Settings), and Region - Global Forecast to 2030"

By product, integrated CDSS is used by healthcare providers because it improves the quality of care.

Based on product global CDSS market is segmented into integrated CDSS and Standalone CDSS. The integrated CDSS is the leading product segment and will grow at a faster pace because of the huge demand for solutions with interoperability and data sharing capabilities. The rise in awareness and adoption of EHR by multi-specialty hospitals will support the growth of the integrated CDSS. 

Global CDSS Market Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of Global CDSS Market

“Asia Pacific to witness significant growth from 2023 to 2030.”

The Asia Pacific is expected to have the fastest growth during the forecast period owing to the presence of old age population, improved government legislation, increase in chronic diseases, increase in investment expenditure in the healthcare sector in countries such as China, Australia, India, and Singapore, and the growing focus of market players on the emerging Asian countries will propel the demand for CDSS market in Asia.

Some of the major players in the global CDSS market include Cerner Corporation, Epic Systems Corporation, Medical Information Technology, Inc., Wolter Kluwer N.V., Zynx Health Incorporated, Elsevier, IBM Watson Health, Allscripts Healthcare, LLC, Siemens Healthcare GmbH, and McKesson Corporation.

Scope of the Report

Global CDSS Market Coverage

Product Insight and Forecast 2025-2030

• Integrated CDSS
• Standalone CDSS

Mode of Delivery Insight and Forecast 2025-2030

• On Premise Delivery Model
• Web-Based Delivery Model
• Cloud-Based Delivery Model

Model Insight and Forecast 2025-2030

• Knowledge-Based CDSS
• Non-Knowledge Based CDSS

Component Insight and Forecast 2025-2030

• Hardware
• Software
• Services

Application Insight and Forecast 2025-2030

• Drug-Drug Interactions
• Drug Allergy Alerts
• Clinical Reminders
• Clinical Guidelines
• Drug Dosing Support
• Others

Level of Interactivity Insight and Forecast 2025-2030

• Active CDSS
• Passive CDSS

Settings Insight and Forecast 2025-2030

• Inpatient Settings
• Ambulatory Care Settings

Geographical Segmentation

CDSS Market by Region

North America

• By Product
• By Mode of Delivery
• By Model
• By Component
• By Application
• By Level of Interactivity
• By Settings
• By Country – U.S., Canada, and Mexico

Europe

• By Product
• By Mode of Delivery
• By Model
• By Component
• By Application
• By Level of Interactivity
• By Settings
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product
• By Mode of Delivery
• By Model
• By Component
• By Application
• By Level of Interactivity
• By Settings
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product
• By Mode of Delivery
• By Model
• By Component
• By Application
• By Level of Interactivity
• By Settings
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries